2. Gene
  3. C5 - complement C5 Gene

C5 - complement C5 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Macaca fascicularis

基因 ID: 102125658 | 基因类型: protein coding

关于 C5

C5 基因产物(4)

mRNA Protein Name
XM_005580915.3 XP_005580972.2 complement C5 isoform X1
XM_045373761.1 XP_045229696.1 complement C5 isoform X3
XM_045373760.1 XP_045229695.1 complement C5 isoform X2
XM_015436776.2 XP_015292262.2 complement C5 isoform X4
蛋白主名 其他名称

complement C5

重组 C5 蛋白

目录号 产品名 蛋白编号 纯度
HY-P78595 Complement C5/C5a Protein, Cynomolgus XP_015292262.1 (M678-R751) ≥95%

相关产品

Approval
生物活性分子 (12)
目录号 产品名 作用方式
纯度 是否罕见病
HY-14541 Olanzapine 99.96% 是
HY-17627 Avacopan Inhibitor 98.50% 是
HY-147080 Avacincaptad pegol sodium Inhibitor 98.53% 否
HY-P3502 Zilucoplan Inhibitor 99.71% 否
HY-B1213 Trimipramine maleate 99.82% 否
HY-32329A Setiptiline maleate Antagonist 99.94% 否
HY-32329 Setiptiline 98.03% 否
HY-14541R Olanzapine (Standard) 99.98% 否
HY-B2169 Melperone 99.84% 是
HY-148457 Avacincaptad pegol Inhibitor / 否
HY-B1213A Trimipramine / 否
HY-P3502A Zilucoplan TFA Inhibitor / 否
抗体抑制剂 (5)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P99394 Talquetamab 98.52% 否
HY-P9914 Eculizumab Inhibitor 97.81% 否
HY-P99365 Ravulizumab Inhibitor 95.57% 否
HY-P99965 Crovalimab Inhibitor 99.59% 否
HY-P99786 Pozelimab Inhibitor 99.42% 否
Clinical Phase
生物活性分子 (11)
目录号 产品名 作用方式
纯度 Phase
HY-E70206 CpG Methyltransferase / Phase 4
HY-14541A Olanzapine hydrochloride / Phase 4
HY-145720 Cemdisiran Inhibitor 95.24% Phase 3
HY-101324A MK-212 monohydrochloride Agonist 99.69% Phase 3
HY-101324 MK-212 Agonist / Phase 3
HY-103109 Melperone hydrochloride / Phase 3
HY-106178 PMX-53 Antagonist 99.85% Phase 2
HY-111200 Vabicaserin hydrochloride Agonist 99.47% Phase 2
HY-102057 Felcisetrag Agonist 99.94% Phase 2
HY-19283 DU125530 Antagonist / Phase 2
HY-123044 Tedatioxetine Antagonist / Phase 1
抗体抑制剂 (6)
目录号 产品名 作用方式
纯度 Phase
HY-P99520 Vilobelimab Inhibitor 99.27% Phase 3
HY-P99638 Gefurulimab Inhibitor 97.88% Phase 3
HY-P99886 Pexelizumab Inhibitor / Phase 3
HY-P99450 Avdoralimab Inhibitor 99.25% Phase 2
HY-P99322 Tesidolumab Inhibitor 97.01% Phase 2
HY-P99767 Olendalizumab Inhibitor 97.43% Phase 2
Pre-clinical Phase
生物活性分子 (503)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-13419 U-73122 Inhibitor 99.79% 否
HY-N0390S1 L-Glutamine-13C5 99.93% 否
HY-149652 IRF5-IN-1 Inhibitor 99.91% 否
HY-138161 JR14a Antagonist 99.59% 否
HY-110136A PMX 205 Trifluoroacetate Antagonist 99.50% 否
HY-128729 DNA2 inhibitor C5 Inhibitor 98.51% 否
HY-D1612 BODIPY FL C5-Ceramide 99.65% 否
HY-103124 DOI hydrochloride Agonist 99.61% 否
HY-103152 GR 113808 Antagonist 99.96% 否
HY-N0049 Nuciferine 99.90% 否
HY-108630 U-73343 99.43% 否
HY-B0228S1 Adenosine-13C5 99.9% 否
HY-148141 JPE-1375 Antagonist 99.96% 否
HY-W013636S 2-Ketoglutaric acid-13C5 99.1% 否
HY-N0092S2 Inosine-13C5 Agonist 99.90% 否
HY-W008820 Glutaric acid 98.44% 否
HY-107836 Methiothepin mesylate Antagonist 99.60% 否
HY-N0326S5 L-Methionine-13C5 99.4% 否
HY-Y0252S L-Proline-13C5 99.00% 否
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 99.80% 否
HY-14608S3 L-Glutamic acid-13C5,15N 99.9% 否
HY-N0717S6 L-Valine-13C5 99.6% 否
HY-W008820S Glutaric acid-d6 98.0% 否
HY-126523 N3-C5-NHS ester ≥98.0% 否
HY-14608S5 L-Glutamic acid-13C5 98.0% 否
HY-W004710 NH2-C5-NH-Boc 99.88% 否
HY-16992A W-54011 99.57% 否
HY-110136 PMX 205 Antagonist 99.78% 否
HY-145237 BM213 99.81% 否
HY-164088 DBM-C5-VC-PAB-MMAE Inhibitor 99.45% 否
HY-D1610 BODIPY FL C5 99.68% 否
HY-128342 Complement C5-IN-1 Inhibitor 99.14% 否
HY-103151 CP94253 hydrochloride Agonist 98.84% 否
HY-132248 C5 Lenalidomide Inhibitor 99.62% 否
HY-B0445S NAD+-13C5 ammonium 98.89% 否
HY-N0390S6 L-Glutamine-13C5,15N2 98.0% 否
HY-130946 NH2-C5-PEG4-N3-L-Lysine-PEG3-N3 99.42% 否
HY-157080 Dibromomaleimide-C5-COOH 99.40% 否
HY-P0014S1 Liraglutide-13C5,15N TFA Agonist 98.19% 否
HY-W008820S1 Glutaric acid-d4 98.0% 否
HY-110060 NDT 9513727 Antagonist 99.35% 否
HY-151667 Biotin-C5-Azide 98.92% 否
HY-141840 GLP-1R modulator C5 Modulator 99.60% 否
HY-W017018S2 L-Ornithine-1,2,3,4,5-13C5 hydrochloride 99.5% 否
HY-W052508 Norquetiapine 99.95% 否
HY-D1613 BODIPY FL C5-HPC 99.43% 否
HY-N0717S1 L-Valine-13C5,15N 98.0% 否
HY-Y0252S4 L-Proline-13C5,15N 99.60% 否
HY-Y0520S Itaconic acid-13C5 ≥97.00% 否
HY-B1449S10 Uridine-13C5 99.90% 否
HY-130703 5-Dehydroepisterol Inhibitor 92.36% 否
HY-148671 (S,R,S)-AHPC-amido-C7-acid 98.71% 否
HY-W006057AS16 Sodium 3-methyl-2-oxobutanoate-13C5 99.00% 否
HY-N0326S6 L-Methionine-13C5,15N 99.20% 否
HY-P5506 C5a Receptor agonist, W5Cha Agonist 99.50% 否
HY-B1511S Cyclic AMP-13C5 97.45% 否
HY-137905 Pomalidomide-amido-C5-PEG2-C6-chlorine 99.69% 否
HY-160241 Lenalidomide-C5-acid 96.36% 否
HY-B2176S6 ATP-13C10 dilithium 98% 否
HY-RI00540 hsa-miR-30c-5p inhibitor 96.54% 否
HY-W018772S15 D-Ribose(mixture of isomers)-13C5 99.90% 否
HY-N0091S2 Hypoxanthine-13C5 98.0% 否
HY-122725B Lenalidomide-C5-NH2 hydrochloride 98.44% 否
HY-136237 Thalidomide-NH-C5-NH2 hydrochloride Inducer 99.86% 否
HY-103129 SB-200646A Antagonist 99.89% 否
HY-138848A Thalidomide-4-O-C5-NH2 hydrochloride Inducer 96.87% 否
HY-N0390S3 L-Glutamine-13C5,15N2,d5 99.91% 否
HY-N0538S2 Xylitol-5-13C 98.0% 否
HY-R00540A hsa-miR-30c-5p agomir 96.15% 否
HY-RI00007A hsa-let-7c-5p antagomir 98.65% 否
HY-W010184S 4,6-Dioxoheptanoic acid-13C5 99.8% 否
HY-W050162 (E)-3,4,5-Trimethoxycinnamic acid 99.95% 否
HY-P1033S1 [Pyr1]-Apelin-13, Pro(13C5,15N) TFA 99.85% 否
HY-P10639 C5aR2 agonist P32 Agonist 99.82% 否
HY-129608 Lenalidomide-acetylene-C5-COOH 99.26% 否
HY-14541S Olanzapine-d3 99.09% 否
HY-130798 (S,R,S)-AHPC-amido-C5-acid 99.58% 否
HY-145720A Cemdisiran sodium 96.02% 否
HY-113038AS α-Hydroxyglutaric acid-13C5 disodium 99.80% 否
HY-125818S3 Cytidine-5'-triphosphate-13C9 dilithium 99.0% 否
HY-14608S6 L-Glutamic acid-5-13C 98.0% 否
HY-15543A CP-809101 hydrochloride Agonist 99.37% 否
HY-R00540 hsa-miR-30c-5p mimic 98.33% 否
HY-B1654S Flavin adenine dinucleotide-13C5 ammonium 90.08% 否
HY-W010256S3 D-Xylulose-13C5 99.9% 否
HY-130849 (S,R,S)-AHPC-Me-C5-COOH 96.87% 否
HY-107372S2 Uridine triphosphate-13C9 dilithium 98.0% 否
HY-117971 BVT173187 Inhibitor 99.97% 否
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 95.02% 否
HY-130530 AP-C5 98.14% 否
HY-132141 5-PA-dUTP 99.59% 否
HY-136187A (S,R,S)-AHPC-C5-NH2 dihydrochloride 97.8% 否
HY-14608S4 L-Glutamic acid-13C5,15N,d5 99.0% 否
HY-153098A ARC186 sodium Inhibitor 94.13% 否
HY-155672 JPC0323 Modulator 99.5% 否
HY-16938S 5'-Methylthioadenosine-13C6 98.45% 否
HY-172911 SHP2-IN-37 Inhibitor / 否
HY-R00007 hsa-let-7c-5p mimic 91.21% 否
HY-R00007A hsa-let-7c-5p agomir 99.93% 否
HY-R00514 hsa-miR-29c-5p mimic 96.59% 否
HY-R01569 hsa-miR-518c-5p mimic 91.42% 否
HY-RI00334 hsa-miR-181c-5p inhibitor 97.20% 否
HY-RI00540A hsa-miR-30c-5p antagomir 95.34% 否
HY-W096148 Biotin-C4-amide-C5-NH2 97.0% 否
HY-153785 NH2-C6-ARC186 sodium Inhibitor 92.50% 否
HY-160901 CP-289,503 Inhibitor 98.21% 否
HY-N0322S3 Cholesterol-13C5 Agonist 99.5% 否
HY-W779017 Thymidine-13C5 Inhibitor 99.90% 否
HY-Y0051S 5-Hydroxymethylfurfural-13C6 Inhibitor 98.0% 否
HY-136055 (S,R,S)-AHPC-C5-COOH Inhibitor 98.81% 否
HY-16637S3 Folic acid-13C5 95.0% 否
HY-131889 Thalidomide-O-C5-acid Inducer 95.82% 否
HY-101343 RS 39604 Antagonist 98.0% 否
HY-101755 Tedatioxetine hydrobromide Antagonist 99.83% 否
HY-108372 Boc-C5-O-C5-O-C6-Cl / 否
HY-112199 CP-447697 Antagonist 99.70% 否
HY-131455A Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA 98.0% 否
HY-132856 Lenalidomide-C5-amido-Boc 95.10% 否
HY-139336 Pomalidomide-C5-azide 97.46% 否
HY-150918S 5-Methyl-1H-pyrazole-3-propanoic acid-13C5 / 否
HY-153098 ARC186 Inhibitor 94.13% 否
HY-156532 5-HT2C agonist-3 Agonist 99.86% 否
HY-156532C (-)-5-HT2C agonist-3 Agonist / 否
HY-161939 7030B-C5 Inhibitor 99.78% 否
HY-76082S1 L-Pyroglutamic acid-13C5 / 否
HY-B2176S7 ATP-13C2 dilithium / 否
HY-N0305S3 5-Aminolevulinic acid-13C-1 hydrochloride 98.0% 否
HY-P4820A SYNV-cyclo(CGGYF) TFA Inhibitor 97.08% 否
HY-RI00408 hsa-miR-200c-5p inhibitor 97.37% 否
HY-W008585 Benzo-15-crown-5-ether 99.02% 否
HY-W040055S Neopterin-13C5 97.53% 否
HY-W753593 N4-Acetylcytidine-13C5 / 否
HY-113046S 5-Methyltetrahydrofolic acid-13C5 98.0% 否
HY-135916 Biotin-C5-amino-C5-amino ≥98.0% 否
HY-14879S2 Avibactam sodium salt-13C5 Inhibitor 99.9% 否
HY-159064S DSPSAPVNVT(Val-13C5,15N)R TFA 95.00% 否
HY-N0091S Hypoxanthine-13C5,15N4 ≥99.0% 否
HY-N7032S1 Uridine 5′-diphosphoglucose-13C6 disodium 98.35% 否
HY-W028210 O-Phthalimide-C5-acid ≥98.0% 否
HY-W654041 Adenosine monophosphate-13C5 96.33% 否
HY-122725A Lenalidomide-C5-NH2 TFA 98.94% 否
HY-141423 Thalidomide-O-amide-C5-NH2 Inducer / 否
HY-141423A Thalidomide-O-amide-C5-NH2 TFA Inducer / 否
HY-15398S4 Vitamin D3-13C5 / 否
HY-175260 ZN-c5 Degrader / 否
HY-N0437S1 Progesterone-13C5 Agonist / 否
HY-W015913S4 2-Oxopropanoate-13c2 sodium / 否
HY-Y1055S4 Guanine-13C5 Chemical ≥95.0% 否
HY-130847 (S,R,S)-AHPC-Me-C10-NH2 96.19% 否
HY-W052508S Norquetiapine-d8 / 否
HY-100582S3 Ribitol-5-13C / 否
HY-101208 L694247 Agonist / 否
HY-101208A L694247 TFA Agonist / 否
HY-101981S4 Uridine 5'-monophosphate-13C9 dilithium Activator / 否
HY-103120 Org37684 Antagonist / 否
HY-103129A SB-200646 Antagonist / 否
HY-103144 WAY 629 hydrochloride Agonist / 否
HY-103144A WAY 629 Agonist / 否
HY-103151A CP94253 Agonist / 否
HY-106400 EGIS 11150 Antagonist / 否
HY-108487 N-Acetyl-O-phosphono-Tyr-Glu dipentylamide Inhibitor / 否
HY-10984S3 Pomalidomide-15N,13C5 Inducer / 否
HY-112675S 4-Octyl itaconate-13C5-1 / 否
HY-113062S 20α-Dihydroprogesterone-13C5 / 否
HY-113066S1 Guanosine 5'-diphosphate-13C10 dilithium Activator 98.7% 否
HY-113075S 1,5-Anhydrosorbitol-13C / 否
HY-113266S Valerylcarnitine-d9 / 否
HY-113359AS1 Uridine 5'-diphosphate-13C9 dilithium Agonist / 否
HY-113420S2 11-Dehydro-thromboxane B2-13C5 / 否
HY-120498 RS-64459-193 Agonist / 否
HY-123704 CGS-12066 maleate Agonist / 否
HY-124117 LY 278584 Antagonist / 否
HY-124310 PDE5-IN-6c / 否
HY-129085 5-Methyl cromolyn disodium / 否
HY-12956S2 Dinoprost-13C5 / 否
HY-130712 NH2-C2-amido-C2-Boc / 否
HY-132939 2-(2,6-Dioxopiperidin-3-yl)phthalimidine-C5-Br Chemical / 否
HY-134737 Boc-NH-PEG1-C5-OH / 否
HY-134986 Thalidomide-NH-C5-NH2 Inducer / 否
HY-136187 (S,R,S)-AHPC-C5-NH2 / 否
HY-138098 Sartorypyrone B / 否
HY-138848 Thalidomide-4-O-C5-NH2 Inducer / 否
HY-138851 Thalidomide-NH-amido-C5-NH2 Inducer / 否
HY-138851A Thalidomide-NH-amido-C5-NH2 hydrochloride Inducer / 否
HY-139996 Pomalidomide-C5-Dovitinib / 否
HY-141062 N-Methyl-N'-(azido-PEG2-C5)-Cy5 / 否
HY-141143 MC(C5)-Val-Cit / 否
HY-141593 Modified MMAF-C5-COOH / 否
HY-141857S 5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3 / 否
HY-141902S Fmoc-Glu(OtBu)-OH-13C5,15N 96.0% 否
HY-14291S2 Vildagliptin-13C5,15N Inhibitor / 否
HY-143340 LEB-03-145 / 否
HY-144676 pan-HER-IN-1 / 否
HY-14520S1 Tetrahydrofolic acid-13C5 / 否
HY-14541S2 Olanzapine-d8 / 否
HY-147585 C5aR-IN-1 / 否
HY-147586 C5aR-IN-2 / 否
HY-147587 C5aR-IN-3 / 否
HY-14781S2 Levomefolic acid-13C5 / 否
HY-148326 Glu(OtBu)-Val-Cit-PAB-OH / 否
HY-148362 Pomalidomide-C6-O-C5-O-C4-COOH 98.55% 否
HY-150632 SARS-CoV-2 nsp13-IN-6 Inhibitor / 否
HY-150660S Ercalcidiol-13C5 / 否
HY-150663S Calcitriol-13C5 / 否
HY-153464 CXCR4-IN-1 Inhibitor / 否
HY-155186 SARS-CoV-2 3CLpro-IN-19 Inhibitor / 否
HY-155261 Pomalidomide-5-C5-NH2 hydrochloride / 否
HY-155506 NAMPT degrader-3 Degrader / 否
HY-156532A 5-HT2C agonist-3 free base Agonist / 否
HY-156534 5-HT2A&5-HT2C agonist-1 Agonist / 否
HY-157511 Thalidomide-O-C5-azide / 否
HY-157933 SF-C5-TPP / 否
HY-158627 JPC0323 Oleate Modulator / 否
HY-158992S SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT TFA / 否
HY-159570 XD2-149 / 否
HY-159571 Thalidomide-NH-C5-azacyclohexane-N-Boc / 否
HY-159572 NH2-C5-Azacyclohexane-N-Boc / 否
HY-160077 Pomalidomide-CO-C5-azide / 否
HY-161132 Lenalidomide 4'-alkyl-C5-azide / 否
HY-161793 (S,R,S)-AHPC-NHCO-C-O-C5-N3 / 否
HY-162950 Piperidin-4-amine-C5-O-C1-Thalidomide / 否
HY-163378 C5aR1 antagonist 1 Antagonist / 否
HY-163379 C5aR1 antagonist 2 Antagonist / 否
HY-163788 C5-CONH-C2-N-CH3 / 否
HY-16384 L-156602 Antagonist / 否
HY-164084 DBCO-NHCO-C5-O-phenylethenesulfonyl fluoride / 否
HY-164829 Mal-C5-Gly-Gly-Phe-MMAE Inhibitor / 否
HY-16567S Asenapine-13C,d3 hydrochloride Antagonist / 否
HY-16637S2 (Rac)-Folic acid-13C5,15N / 否
HY-16637S4 Folic acid-13C5,15N / 否
HY-168039 Boc-NH-Piperidine-C5-OH / 否
HY-168040 Thalidomide-O-C5-piperidine-NH-Boc / 否
HY-168175 PROTAC HDAC8 Degrader-2 / 否
HY-168334 5-HT2C agonist-4 Agonist / 否
HY-169010 Pomalidomide-CO-C5-Br / 否
HY-170820 XYD049 / 否
HY-172213 (3S,6R)-NML Antagonist / 否
HY-172339 4-AcO-DALT hydrochloride Inhibitor / 否
HY-172645 (S,R,S)-AHPC-Me-amide-C-O-C5-Br / 否
HY-173010 Me-(S,R,S)-AHPC-CO-C5-N3 / 否
HY-173419 5-cis-15(R)-Iloprost / 否
HY-17383S Levomefolate-13C5 calcium Chemical / 否
HY-174898 5-HT2C agonist-9 Agonist / 否
HY-175194 5-HT2C agonist-6 Agonist / 否
HY-175514 5-HT2C agonist-10 Activator / 否
HY-175515 5-HT2C agonist-11 Agonist / 否
HY-176216 5-HT2C agonist-5 Agonist / 否
HY-176277S Fibrinopeptide B, human-(Val-13C5,15N, Arg-13C6,15N4) TFA / 否
HY-176794 Phenyl-glutarimide 4'-oxyacetic-amide-C5-amide-Boc / 否
HY-177094 Izicopan Antagonist / 否
HY-18252S1 Avanafil-13C5,15N,d2 / 否
HY-21994 Org-12962 hydrochloride Agonist / 否
HY-32351AS1 Calcifediol-13C5 monohydrate / 否
HY-A0003S2 Lenalidomide-13C5,15N Inducer / 否
HY-B0152S2 Adenine-13C5,15N5 Chemical 95% 否
HY-B0389S17 D-Glucose-13C-5 98.0% 否
HY-B0434S Ribavirin-13C5 Inhibitor / 否
HY-B0456S2 Riboflavin-13C5 / 否
HY-B0660S1 Eicosapentaenoic acid 1,2,3,4,5-13C5 Activator / 否
HY-B1204S2 Histamine-13C5, 15N3 / 否
HY-D1592 BODIPY TMR C5-maleimide / 否
HY-D1611 BODIPY FL-C5 NHS Ester / 否
HY-E70633 PIP5K1C Recombinant Human Active Lipid Kinase / 否
HY-I1111S3 Fmoc-L-Val-OH-13C5 / 否
HY-N0049R Nuciferine (Standard) / 否
HY-N0210S4 D-Galactose-13C-5 / 否
HY-N0379S10 D-Mannose-13C-5 / 否
HY-N0537S4 Xylose-5-13C / 否
HY-N0717S2 L-Valine-13C5,15N,d8 / 否
HY-N0717S3 L-Valine-13C5,15N,d2 / 否
HY-N12728 Heteroclitin G / 否
HY-N13081 3-Oxo-cinobufagin / 否
HY-N3406 Lansiumarin C / 否
HY-N5134S1 5'-Guanylic acid-13C10 dilithium / 否
HY-N7082S D-Arabinopyranose-13C5 99.9% 否
HY-NP202C C5 Protein (human) / 否
HY-P10274 CM05 Inhibitor / 否
HY-P10653 C5A Inhibitor / 否
HY-P4820 SYNV-cyclo(CGGYF) Inhibitor / 否
HY-P4971 C5a Anaphylatoxin (human) Modulator / 否
HY-R00334 hsa-miR-181c-5p mimic / 否
HY-R00334A hsa-miR-181c-5p agomir / 否
HY-R00408 hsa-miR-200c-5p mimic / 否
HY-R00408A hsa-miR-200c-5p agomir / 否
HY-R00514A hsa-miR-29c-5p agomir / 否
HY-R00718 hsa-miR-34c-5p mimic / 否
HY-R00718A hsa-miR-34c-5p agomir / 否
HY-R00833 hsa-miR-374c-5p mimic / 否
HY-R00833A hsa-miR-374c-5p agomir / 否
HY-R00841 hsa-miR-376c-5p mimic / 否
HY-R00841A hsa-miR-376c-5p agomir / 否
HY-R01113 hsa-miR-449c-5p mimic / 否
HY-R01113A hsa-miR-449c-5p agomir / 否
HY-R01547 hsa-miR-513c-5p mimic / 否
HY-R01547A hsa-miR-513c-5p agomir / 否
HY-R01569A hsa-miR-518c-5p agomir / 否
HY-R02507 hsa-miR-892c-5p mimic / 否
HY-R02507A hsa-miR-892c-5p agomir / 否
HY-R02796 mmu-miR-1970c-5p mimic / 否
HY-R02796A mmu-miR-1970c-5p agomir / 否
HY-R02834 mmu-miR-216c-5p mimic / 否
HY-R02834A mmu-miR-216c-5p agomir / 否
HY-R02841 mmu-miR-219c-5p mimic / 否
HY-R02841A mmu-miR-219c-5p agomir / 否
HY-R02883 mmu-miR-297c-5p mimic / 否
HY-R02883A mmu-miR-297c-5p agomir / 否
HY-R02898 mmu-miR-302c-5p mimic / 否
HY-R02898A mmu-miR-302c-5p agomir / 否
HY-R03044 mmu-miR-344c-5p mimic / 否
HY-R03044A mmu-miR-344c-5p agomir / 否
HY-R03105 mmu-miR-374c-5p mimic / 否
HY-R03105A mmu-miR-374c-5p agomir / 否
HY-R03112 mmu-miR-376c-5p mimic / 否
HY-R03112A mmu-miR-376c-5p agomir / 否
HY-R03149 mmu-miR-449c-5p mimic / 否
HY-R03149A mmu-miR-449c-5p agomir / 否
HY-R03164 mmu-miR-465c-5p mimic / 否
HY-R03164A mmu-miR-465c-5p agomir / 否
HY-R03171 mmu-miR-466c-5p mimic / 否
HY-R03171A mmu-miR-466c-5p agomir / 否
HY-R03199 mmu-miR-467c-5p mimic / 否
HY-R03199A mmu-miR-467c-5p agomir / 否
HY-R03461 mmu-miR-669c-5p mimic / 否
HY-R03461A mmu-miR-669c-5p agomir / 否
HY-R04278 rno-miR-196c-5p mimic / 否
HY-R04278A rno-miR-196c-5p agomir / 否
HY-R04285 rno-miR-200c-5p mimic / 否
HY-R04285A rno-miR-200c-5p agomir / 否
HY-R04448 rno-miR-376c-5p mimic / 否
HY-R04448A rno-miR-376c-5p agomir / 否
HY-R04485 rno-miR-466c-5p mimic / 否
HY-R04485A rno-miR-466c-5p agomir / 否
HY-RI00007 hsa-let-7c-5p inhibitor / 否
HY-RI00334A hsa-miR-181c-5p antagomir / 否
HY-RI00408A hsa-miR-200c-5p antagomir / 否
HY-RI00514 hsa-miR-29c-5p inhibitor / 否
HY-RI00514A hsa-miR-29c-5p antagomir / 否
HY-RI00718 hsa-miR-34c-5p inhibitor / 否
HY-RI00718A hsa-miR-34c-5p antagomir / 否
HY-RI00833 hsa-miR-374c-5p inhibitor / 否
HY-RI00833A hsa-miR-374c-5p antagomir / 否
HY-RI00841 hsa-miR-376c-5p inhibitor / 否
HY-RI00841A hsa-miR-376c-5p antagomir / 否
HY-RI01113 hsa-miR-449c-5p inhibitor / 否
HY-RI01113A hsa-miR-449c-5p antagomir / 否
HY-RI01547 hsa-miR-513c-5p inhibitor / 否
HY-RI01547A hsa-miR-513c-5p antagomir / 否
HY-RI01569 hsa-miR-518c-5p inhibitor / 否
HY-RI01569A hsa-miR-518c-5p antagomir / 否
HY-RI02507 hsa-miR-892c-5p inhibitor / 否
HY-RI02507A hsa-miR-892c-5p antagomir / 否
HY-RI02796 mmu-miR-1970c-5p inhibitor / 否
HY-RI02796A mmu-miR-1970c-5p antagomir / 否
HY-RI02834 mmu-miR-216c-5p inhibitor / 否
HY-RI02834A mmu-miR-216c-5p antagomir / 否
HY-RI02841 mmu-miR-219c-5p inhibitor / 否
HY-RI02841A mmu-miR-219c-5p antagomir / 否
HY-RI02883 mmu-miR-297c-5p inhibitor / 否
HY-RI02883A mmu-miR-297c-5p antagomir / 否
HY-RI02898 mmu-miR-302c-5p inhibitor / 否
HY-RI02898A mmu-miR-302c-5p antagomir / 否
HY-RI03044 mmu-miR-344c-5p inhibitor / 否
HY-RI03044A mmu-miR-344c-5p antagomir / 否
HY-RI03105 mmu-miR-374c-5p inhibitor / 否
HY-RI03105A mmu-miR-374c-5p antagomir / 否
HY-RI03112 mmu-miR-376c-5p inhibitor / 否
HY-RI03112A mmu-miR-376c-5p antagomir / 否
HY-RI03149 mmu-miR-449c-5p inhibitor / 否
HY-RI03149A mmu-miR-449c-5p antagomir / 否
HY-RI03164 mmu-miR-465c-5p inhibitor / 否
HY-RI03164A mmu-miR-465c-5p antagomir / 否
HY-RI03171 mmu-miR-466c-5p inhibitor / 否
HY-RI03171A mmu-miR-466c-5p antagomir / 否
HY-RI03199 mmu-miR-467c-5p inhibitor / 否
HY-RI03199A mmu-miR-467c-5p antagomir / 否
HY-RI03461 mmu-miR-669c-5p inhibitor / 否
HY-RI03461A mmu-miR-669c-5p antagomir / 否
HY-RI04278 rno-miR-196c-5p inhibitor / 否
HY-RI04278A rno-miR-196c-5p antagomir / 否
HY-RI04285 rno-miR-200c-5p inhibitor / 否
HY-RI04285A rno-miR-200c-5p antagomir / 否
HY-RI04448 rno-miR-376c-5p inhibitor / 否
HY-RI04448A rno-miR-376c-5p antagomir / 否
HY-RI04485 rno-miR-466c-5p inhibitor / 否
HY-RI04485A rno-miR-466c-5p antagomir / 否
HY-RS01749 C5 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01750 C5AR1 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS01751 C5AR2 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS12597 SDR16C5 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W000450S 5-Aminolevulinic acid-13C / 否
HY-W008048S 2',3'-O-Isopropylideneadenosine-13C5 / 否
HY-W008371S1 Fmoc-Met-OH-13C5,15N / 否
HY-W008820S2 Glutaric acid-d2 / 否
HY-W009538S1 5'-Deoxy-5-fluorocytidine-13C5 / 否
HY-W010918S3 Adenosine 5'-diphosphate-13C5 / 否
HY-W011683S3 2'-Deoxyadenosine monohydrate-5′-13C / 否
HY-W016145S L-Glutamic acid-13C5 hydrate salt / 否
HY-W017401S Benzisothiazolinone-13C6 Inhibitor / 否
HY-W040047S Pregnanediol 3-glucuronide-13C5 / 否
HY-W096134 Benzyloxy-C5-PEG1 / 否
HY-W143131S Diethyl itaconate,98% (stabilized with TBC)-13C5 / 否
HY-W392933S3 Thymidine 5'-monophosphate-13C10 dilithium / 否
HY-W393970S2 2′-Deoxyguanosine 5′-monophosphate-13C10 dilithium / 否
HY-W400722 Sodium 3-methyl-2-oxobutanoate-13C5,d1 / 否
HY-W746880 D-Arabinose Phenylhydrazone-13C5 / 否
HY-W749825 Pentetic acid-13C5 / 否
HY-W750576 4-Octyl itaconate-13C5 / 否
HY-W751746 Dehydro Folic Acid 1,5-Dimethyl Ester-13C5 / 否
HY-W751764 Dehydro Folic Acid 1,5-Dimethyl Ester-13C5,15N / 否
HY-W753201 5'-Methylthioadenosine-13C / 否
HY-W754064 Cytidine-5'-triphosphate-13C5 / 否
HY-W755003 Guanosine-13C5 / 否
HY-W756758 Guanosine-13C5 5'-Monophosphate / 否
HY-W767865 Cyclic GMP sodium-13C5 / 否
HY-W768207 Cytidine-1',2',3',4',5'-13C5 / 否
HY-W768213 2'-Deoxyguanosine monohydrate-13C5 / 否
HY-W768275 Glucopyranose-13C5 / 否
HY-W768283 Guanosine Hydrate-13C5 / 否
HY-W768302 D-Lyxose-13C5 / 否
HY-W768324 Ribitol-13C5 / 否
HY-W768333 D-Ribofuranose-13C5 / 否
HY-W768347 Xylitol-13C5 / 否
HY-W769288 Pemetrexed disodium-13C5 / 否
HY-W769319 Inosinic acid-13C5 / 否
HY-W777286 rac-Lenalidomide-13C5 / 否
HY-W778297 5,6-Diamino-4-thiouracil-13C2 / 否
HY-W778990 2-Deoxyuridine-1,2,3,4,5-13C5 / 否
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) 96.25% 否
HY-Y0252S6 L-Proline-13C5,15N,d7 / 否
HY-Y1055S2 Guanine-13C5,15N5 Chemical / 否
HY-Y1166S N-(9-Fluorenylmethoxycarbonyl)glutamic acid α-tert-butyl ester-13C5,15N / 否
HY-100805S1 D-Glutamic acid-13C5,15N / 否
HY-100805S2 D-Glutamic acid-13C5 / 否
HY-106178D PMX 53 monoacetate / 否
HY-10984S4 Pomalidomide-13C5 Inducer / 否
HY-111592S S-(5′-Adenosyl)-L-cysteine-13C / 否
HY-113209S2 8-Isoprostaglandin F2α-13C5 / 否
HY-117872 Sartorypyrone A / 否
HY-133411A NH2-O-C5-COOH hydrobromide / 否
HY-13599S1 Cladribine-13C5,15N2 / 否
HY-143704S 5-Aminosalicylic acid-13C6 hydrochloride 99.53% 否
HY-144345S L-γ-Glutamyl-L-cysteinyl-L-lysine-13C5,15N / 否
HY-147338S1 5-Methylcytidine 5′-triphosphate-15N2,13C trisodium / 否
HY-149562 Thalidomide-5-O-C5-NH2 hydrochloride / 否
HY-149691 O-Phthalimide-C1-S-C5-acid / 否
HY-149751 Methylthiomcresol-C5-COOH / 否
HY-150661S 3-epi-Calcifediol-13C5 / 否
HY-15401A WAY 163909 hydrochloride / 否
HY-15543 CP-809101 Agonist / 否
HY-158382 NH2-C4-PEG4-C5-COOH / 否
HY-159046S ASGITFSNSGMHW(Val-13C5,15N)R TFA / 否
HY-159065S FIQE(Val-13C5,15N)NTTTR TFA / 否
HY-160235 Pomalidomide-C2-amide-C5-azide / 否
HY-161792 N3-C5-O-C-Boc / 否
HY-162948 (S,R,S)-AHPC-PEG2-C5-N3 / 否
HY-162949 Piperidin-4-amine-C5-O-C1 / 否
HY-170796 α-Amylase-IN-11 Inhibitor / 否
HY-173102S LQEEIDAVL(Pro-13C5,15N)NK TFA / 否
HY-173105S TPEEAHALSA(Pro-13C5,15N)TSR TFA / 否
HY-173514 SARS-CoV-2 Mpro-IN-42 Inhibitor / 否
HY-176179S LFFAADHLV(Val-13C5,15N)CE / 否
HY-176336 Thalidomide-C-amide-C5-amine / 否
HY-18206S2 Lisinopril-13C5,15N / 否
HY-18252S3 Avanafil-13C5 / 否
HY-18767S2 Ivosidenib-13C5 Inhibitor / 否
HY-32329S Setiptiline-d3 / 否
HY-403544 CbzNH-(C5-O)2-C4-Boc / 否
HY-50719S1 2-Acetyl-1-pyrroline-13C5 / 否
HY-A0004S Decitabine-13C5 / 否
HY-B0152S3 Adenine-13C5 Chemical / 否
HY-B0368S1 Captopril-13C5,15N Inhibitor / 否
HY-B0511S3 Biotin-13C5 / 否
HY-B1204S3 Histamine-13C5 / 否
HY-B1213S Trimipramine-d3 maleate / 否
HY-B2130S2 Uric acid-13C5 / 否
HY-B2169S2 Melperone-d4 hydrochloride 99.84% 否
HY-I1111S2 Fmoc-L-Val-OH-13C5,15N 98% 否
HY-N0782 Isoprene / 否
HY-N13147 Tetromycin C5 Inhibitor / 否
HY-P10639A C5aR2 agonist P32 acetate Agonist / 否
HY-P3502B Zilucoplan (PEG2) Inhibitor / 否
HY-RS18377 C5ar1 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS22969 C5 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS24857 C5ar1 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W009162S1 Cytidine 5′-monophosphate-13C9 dilithium / 否
HY-W010450S5 Thymine-13C5,15N2 / 否
HY-W011297S3 Methyl arachidonate-13C5 / 否
HY-W013780S1 Fmoc-Pro-OH-13C5,15N Inhibitor / 否
HY-W039426 N-Trityl-N4-benzoyl-morpholino-C-5'-O-phosphoramidite / 否
HY-W130878 4-Octylphenol Activator / 否
HY-W251144 N,N′-Dipentyl-3,4,9,10-perylenedicarboximide / 否
HY-W338810S S-(5'-Adenosyl)-L-methionine-13C5 sulfate / 否
HY-W728005 Covidcil-19 Inhibitor / 否
HY-W778183 3,5,6-Trichloro-2-pyridinol-13C5 / 否
HY-W778207 2'-Deoxyadenosine-13C5 monohydrate / 否
HY-W779015 5-Methyluridine-13C5 / 否
HY-W779019 Xylose-13C5 / 否
HY-W779800 D-α-Hydroxyglutaric acid-13C5 disodium / 否
HY-W814363 Octadec-9-enoic acid-13C5 / 否
HY-W838632 Antibacterial agent 266 Inhibitor / 否
HY-W013081S Fmoc-Gln(Trt)-OH-13C5,15N2 / 否
HY-101009 Methiothepin maleate Antagonist / 否
HY-111491 Methiothepin Antagonist / 否
抗体抑制剂 (7)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P990608 Alpitatug 99.13% 否
HY-P990753 Omoprubart / 否
HY-P990998 Greziprubart Inhibitor / 否
HY-P991067 Vensobafusp alfa Inhibitor / 否
HY-P991485 Anti-CD88/C5AR1 Antibody (G2_anti-C5aR) Inhibitor / 否
HY-P991657 MEDI7814 Inhibitor / 否
HY-P990745 Izastobart Ligand / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens C5 NCBI NCBI:727
Mus musculus C5 NCBI
Susscrofa domestica C5 NCBI
Leporidae C5 NCBI
Rattus norvegicus C5 NCBI NCBI:362119
Macaca mulatta C5 NCBI NCBI:700467
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z